In atherosclerosis, many studies have supported the role of the chemokine receptor CCR5 and its ligands CCL3, CCL4, and CCL5 in triggering the progression of atherosclerosis, particularly in later stages of plaque. This evidence concerns the gene CCL3 and atherosclerosis.